The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Imperial Capital

Toronto-Based PE Fund Imperial Capital Raises $126 million, Invests in IRB Company Schulman

Imperial Capital, a private equity fund in Toronto, Canada, closed its fourth fund yesterday with $126 million.  Interestingly, they kicked off Fund IV with an investment in Schulman Associates, an independent Institutional Review Board (IRB) company based in Cincinnati, Ohio, that provides:

“IRB services for a variety of study types (primarily Phase II and III multi-site clinical trials) within the United States, Puerto Rico, and Canada”

which will hopefully avoid any Coast-like problems.  Imperial Capital’s other current investments are in cosmetics, hair care and paintball. 

H/T to @CVCACanada.


Get every new post delivered to your Inbox.

Join 128 other followers